535-548
Review
Safety and anti-tumor activity of sorafenib (Nexavar®) in combination with other anti-cancer agents: a review of clinical trials
Chris H. Takimoto and Ahmad Awada
549-558
Original Article
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma
Gavin J. Gordon, Madhubalan Mani, Gautam Maulik, Lipi Mukhopadhyay and Beow Y. Yeap, et al.
559-567
Original Article
Combination of doxorubicin and low-intensity ultrasound causes a synergistic enhancement in cell killing and an additive enhancement in apoptosis induction in human lymphoma U937 cells
Toru Yoshida, Takashi Kondo, Ryohei Ogawa, Loreto B. Feril and Qing-Li Zhao, et al.
569-577
Original Article
Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer
J. Lee, Y. H. Im, S. H. Lee, E. Y. Cho and Y. L. Choi, et al.
579-585
Original Article
A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer
A. R. Clamp, P. Schöffski, J. W. Valle, R. H. Wilson and S. Marreaud, et al.
587-594
Original Article
Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer
Kenji Okumura, Eiji Mekata, Hisanori Shiomi, Hiroyuki Naitoh and Hajime Abe, et al.
595-605
Original Article
Involvement of UDP-glucuronosyltransferase activity in irinotecan-induced delayed-onset diarrhea in rats
Masaharu Onoue, Akinobu Kurita, Shoichi Kado, Tsuneo Matsumoto and Norimasa Kaneda, et al.
607-614
Original Article
Pharmacokinetics and safety of bevacizumab administered in combination with cisplatin and paclitaxel in cynomolgus monkeys
Lu Xu, Christina L. Zuch, Yvonne S. Lin, Nishit B. Modi and Bert L. Lum
615-621
Original Article
A late phase II study of S-1 for metastatic pancreatic cancer
Takuji Okusaka, Akihiro Funakoshi, Junji Furuse, Narikazu Boku and Kenji Yamao, et al.
623-629
Original Article
Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer
Yeon Hee Park, Jae-Lyun Lee, Baek-Yeol Ryoo, Min-Hee Ryu and Sung Hyun Yang, et al.
631-637
Original Article
A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy
Jae-Lyun Lee, Min-Hee Ryu, Heung Moon Chang, Tae-Won Kim and Jeong Hwan Yook, et al.
639-645
Original Article
The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells
Deguang Mu, Wei Zhang, Dongling Chu, Tonggang Liu and Yonghong Xie, et al.
647-652
Original Article
Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates
Stacie L. Stapleton, Patrick A. Thompson, Ching-Nan Ou, Stacey L. Berg and Leticia McGuffey, et al.
653-659
Original Article
A combination of IFN-β and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation
Atsushi Natsume, Toshihiko Wakabayashi, Dai Ishii, Hideharu Maruta and Masazumi Fujii, et al.
661-668
Original Article
Phase II study of thalidomide in patients with metastatic carcinoid and islet cell tumors
Kimberly A. Varker, Jacqueline Campbell and Manisha H. Shah
669-681
Original Article
Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo
Jörg Schwock, Nhu-An Pham, Mary P. Cao and David W. Hedley
683-688
Original Article
A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization
Tsutomu Tanaka, Masafumi Ikeda, Takuji Okusaka, Hideki Ueno and Chigusa Morizane, et al.
689-694
Original Article
A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma
Walter M. Stadler, Apurva A. Desai, David I. Quinn, Ronald Bukowski and Bernard Poiesz, et al.
695-702
Original Article
An open-label study to evaluate dose and cycle dependence of the pharmacokinetics of pegylated liposomal doxorubicin
Alberto Gabizon, Rut Isacson, Ora Rosengarten, Dina Tzemach and Hilary Shmeeda, et al.
703-711
Original Article
The effect of the polyadenylation inhibitor cordycepin on human Molt-4 and Daudi leukaemia and lymphoma cell lines
Hellinida Thomadaki, Chris Milto Tsiapalis and Andreas Scorilas
713-716
Short Communication
PDGFRalpha/FIP1L1-positive chronic eosinophilic leukemia presenting with retro-orbital localization: efficacy of imatinib treatment
Ernesto Vigna, Eugenio Lucia, Massimo Gentile, Carla Mazzone and Maria Grazia Bisconte, et al.
717-720
Short Communication
A case of mixed adult Wilms’ tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO)
Thomas Yau, C. H. Leong, W. K. Chan, J. K. Chan and R. H. S. Liang, et al.